- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00278746
Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting
An Effectiveness Trial Examining the Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This cluster randomized trial aimed at evaluating in a community based controlled effectiveness trial whether addition of 2RDA zinc as a therapeutic modality to the current case management package for diarrhoea in children aged between 1 month and 5 years, delivered through existing channels at village level, resulted in reduction in care seeking from health care providers, antibiotic and other drug use and increase in ORS use rates.
The intervention was being implemented in 6 PHCs; 3 intervention and 3 control.
Based on the experience of a pilot study and the formative research findings, common sources visited by caregivers for care seeking during morbidity were identified. These sources were selected as channels in partnership with the local government, to distribute zinc strips and ORS packets in intervention sites and only ORS packets in control sites. These channels were physicians (at the PHC and private practitioners), the auxiliary nurse midwives (ANMs) and Anganwadi workers (AWWs) of the Integrated Child Development Services (ICDS) Scheme. All the channels were trained and supplies of zinc strips and ORS packets, and ORS packets only were distributed in each pair of PHC in intervention and control sites respectively. Recommendations were developed and translated into local vernacular. A poster, incorporating these recommendations and pictures of zinc strips and ORS packets, was designed and put up at various places in the intervention sites. For outcome measurements, cross sectional surveys were conducted at 6 monthly intervals.
Process evaluation activities, which included observations of different channels and exit interviews with mothers after they had visited a channel were conducted.
In the two groups, zinc was used in 36.5% and 59.8% diarrheal episodes and ORS in 34.8% and 59.2% episodes in the 4 weeks preceding interviews in intervention areas. In control areas, ORS was used in 7.8% and 9.8% episodes. Care seeking for diarrhea, prescription of drugs of unknown identity and antibiotics for diarrhea reduced in intervention communities.
The study demonstrated that an intervention to improve diarrhea management with ORS and zinc is feasible and highly acceptable in rural Indian communities. The resulting health benefits were substantial and accomplished with a reduction in the cost to families for diarrhea treatment from current practices.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Delhi
-
New Delhi, Delhi, India, 110017
- Society for Applied Studies
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children aged 1 month to 5 years with diarrhea
Exclusion Criteria:
- Illness requiring referral to hospital
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Zinc and ORS were promoted for treatment of diarrhea in underfive children
|
Government and private providers and village health workers were trained to prescribe zinc and ORS for use in diarrheal episodes in 1 month to 5 years old children in intervention communities
|
Other: 2
Promoted routine management of diarrhea in underfive with ORS
|
Promoted routine management of diarrhea in underfive with ORS
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To evaluate in a community based controlled effectiveness trial whether addition of zinc as a therapeutic modality for diarrhea delivered through existing channels, including at village level to the current case management package for under-five children
Time Frame: 20 months (Jan 2005 to Sep 2006)
|
20 months (Jan 2005 to Sep 2006)
|
- Reduction in visits to health care providers for treatment of illness
Time Frame: 20 months (Jan 2005 to Sep 2006)
|
20 months (Jan 2005 to Sep 2006)
|
- Reduction in drug use; antibiotics and other drugs during diarrheal illnesses
Time Frame: 20 months (Jan 2005 to Sep 2006)
|
20 months (Jan 2005 to Sep 2006)
|
- Increase in ORS use during diarrhea in the intervention communities.
Time Frame: 20 months (Jan 2005 to Sep 2006)
|
20 months (Jan 2005 to Sep 2006)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
- Reduction in all cause hospitalizations
Time Frame: 20 months (Jan 2005 to Sep 2006)
|
20 months (Jan 2005 to Sep 2006)
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PR-5268/PID/20/198/2004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mortality
-
Duke UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsTerminated
-
University Hospital, Clermont-FerrandAustralian Catholic University; WittyFitUnknown
-
Duke-NUS Graduate Medical SchoolActive, not recruiting
-
Chimei Medical CenterCompleted
-
Queens College, The City University of New YorkNational Cancer Institute (NCI)UnknownMortality
-
FHI 360Ministère de la Santé et de l´Hygiène Publique (Côte d'Ivoire)Recruiting
-
University of California, San FranciscoBill and Melinda Gates Foundation; Centre de Recherche en Sante de Nouna, Burkina...CompletedChildhood MortalityBurkina Faso
-
Public Health Foundation of IndiaUBS Optimus Foundation; The Children's Investment Fund FoundationCompleted
-
Hospital Vila Franca de XiraUnknownHospital MortalityPortugal
Clinical Trials on Zinc and ORS
-
Society for Applied StudiesJohns Hopkins University; World Health OrganizationCompletedDiarrhea | HospitalizationIndia
-
Ferrer Internacional S.A.Axonal-BiostatemCompleted
-
Mayo ClinicCompleted
-
International Centre for Diarrhoeal Disease Research...University Hospital, Basel, SwitzerlandCompletedMalnourished Children With Watery DiarrhoeaBangladesh
-
Society for Applied StudiesCompleted
-
International Centre for Diarrhoeal Disease Research...Karolinska Institutet; Georgetown University; University Hospital, Basel, SwitzerlandCompleted
-
International Centre for Diarrhoeal Disease Research...University of BaselCompleted
-
Medical University of WarsawCompleted
-
University of FloridaNational Institute of Allergy and Infectious Diseases (NIAID)Recruiting